Start Date
March 11, 2020
Primary Completion Date
February 9, 2021
Study Completion Date
February 9, 2021
Administration of SSRI escitalopram
Participants will be administered 5, 10 or 20mg of SRRI escitalopram prior to paired associative stimulation
Paired Associative stimulation
Participants will receive paired associative stimulation (transcranial magnetic stimulation and peripheral nerve stimulation) with an inter-stimulus interval length known to modulate corticospinal excitability.
Administration of Placebo
Participants will be administered a placebo prior to paired associative stimulation
Burke Neurological Institute, White Plains
Lead Sponsor
Burke Medical Research Institute
OTHER